Loading...

Jason Limberis, PhD

Title(s)Postdoctoral Scholar, Medicine
SchoolSchool of Medicine
Address1001 Potrero Ave
San Francisco CA 94110
Phone628-206-8101
Emailjason.limberis@ucsf.edu
ORCID ORCID Icon0000-0002-7893-8416 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stellenbosch University, South AfricaBSc Molecular Biology with Biotechnology
    Stellenbosch University, South AfricaBSc HonsMolecular Biology
    University of Cape Town, South AfricaPhDMedicine
    The Centre for Genomic Regulation, SpainInternshipBioinformatics

    Collapse Overview 
    Collapse Overview
    My research focusses on the causative agent of tuberculosis, Mycobacterium tuberculosis: I apply a combination of wet work and bioinformatics to investigate genomic and transcriptional associates of drug resistance, clinical outcomes, and patient infectiousness. See www.SemiQuant.com for more information.

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Collaboration Interests

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Differential RD-1-specific IFN-? host responses to diverse Mycobacterium tuberculosis strains in HIV-uninfected persons may be explained by genotypic variation in the ESX-1 region. Int J Infect Dis. 2020 Apr 24. Tomasicchio M, Limberis J, van der Merwe R, Jacobson R, Meldau R, Theron G, Nicol M, Warren R, Dheda K. PMID: 32339714.
      View in: PubMed   Mentions:    Fields:    
    2. A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic. BMC Med. 2020 Feb 04; 18(1):24. Klopper M, Heupink TH, Hill-Cawthorne G, Streicher EM, Dippenaar A, de Vos M, Abdallah AM, Limberis J, Merker M, Burns S, Niemann S, Dheda K, Posey J, Pain A, Warren RM. PMID: 32014024.
      View in: PubMed   Mentions:    Fields:    
    3. A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug-resistant tuberculosis. Eur Respir J. 2020 Jan; 55(1). Olayanju O, Esmail A, Limberis J, Dheda K. PMID: 31619478.
      View in: PubMed   Mentions:    Fields:    
    4. A Human Lung Challenge Model to Evaluate the Safety and Immunogenicity of PPD and Live BCG. Am J Respir Crit Care Med. 2019 Dec 20. Davids M, Pooran A, Hermann C, Mottay L, Thompson F, Cardenas J, Gu J, Koeuth T, Meldau R, Limberis J, Gina P, Srivastava S, Calder B, Esmail A, Tomasicchio M, Blackburn J, Gumbo T, Dheda K. PMID: 31860339.
      View in: PubMed   Mentions: 1     Fields:    
    5. Same-Day Tools, Including Xpert Ultra and IRISA-TB, for Rapid Diagnosis of Pleural Tuberculosis: a Prospective Observational Study. J Clin Microbiol. 2019 09; 57(9). Meldau R, Randall P, Pooran A, Limberis J, Makambwa E, Dhansay M, Esmail A, Dheda K. PMID: 31270183.
      View in: PubMed   Mentions:    Fields:    
    6. Linezolid interruption in patients with fluoroquinolone-resistant tuberculosis receiving a bedaquiline-based treatment regimen. Int J Infect Dis. 2019 Aug; 85:74-79. Olayanju O, Esmail A, Limberis J, Gina P, Dheda K. PMID: 31100421.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa. Eur Respir J. 2018 05; 51(5). Olayanju O, Limberis J, Esmail A, Oelofse S, Gina P, Pietersen E, Fadul M, Warren R, Dheda K. PMID: 29700106.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    8. Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study. Lancet Respir Med. 2017 04; 5(4):269-281. Dheda K, Limberis JD, Pietersen E, Phelan J, Esmail A, Lesosky M, Fennelly KP, Te Riele J, Mastrapa B, Streicher EM, Dolby T, Abdallah AM, Ben-Rached F, Simpson J, Smith L, Gumbo T, van Helden P, Sirgel FA, McNerney R, Theron G, Pain A, Clark TG, Warren RM. PMID: 28109869.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    9. Selected questions and controversies about bedaquiline: a view from the field. Int J Tuberc Lung Dis. 2016 12 01; 20(12):24-32. Dheda K, Esmail A, Limberis J, Maartens G. PMID: 28240569.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results? Clin Infect Dis. 2016 Apr 15; 62(8):995-1001. Theron G, Venter R, Calligaro G, Smith L, Limberis J, Meldau R, Chanda D, Esmail A, Peter J, Dheda K. PMID: 26908793.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells